GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunniva Inc (XCNQ:SNN) » Definitions » Total Liabilities

Sunniva (XCNQ:SNN) Total Liabilities : C$76.21 Mil (As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Sunniva Total Liabilities?

Sunniva's Total Liabilities for the quarter that ended in Sep. 2019 was C$76.21 Mil.

Sunniva's quarterly Total Liabilities increased from Mar. 2019 (C$59.06 Mil) to Jun. 2019 (C$66.96 Mil) and increased from Jun. 2019 (C$66.96 Mil) to Sep. 2019 (C$76.21 Mil).

Sunniva's annual Total Liabilities increased from Dec. 2016 (C$11.42 Mil) to Dec. 2017 (C$40.61 Mil) but then declined from Dec. 2017 (C$40.61 Mil) to Dec. 2018 (C$40.31 Mil).


Sunniva Total Liabilities Historical Data

The historical data trend for Sunniva's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunniva Total Liabilities Chart

Sunniva Annual Data
Trend Dec16 Dec17 Dec18
Total Liabilities
11.42 40.61 40.31

Sunniva Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.01 40.31 59.06 66.96 76.21

Sunniva Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sunniva's Total Liabilities for the fiscal year that ended in Dec. 2018 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=19.16+(20.196+5.5511151231258E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.951+0)
=40.31

Total Liabilities=Total Assets (A: Dec. 2018 )-Total Equity (A: Dec. 2018 )
=125.32-85.013
=40.31

Sunniva's Total Liabilities for the quarter that ended in Sep. 2019 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=34.452+(41.761+-7.105427357601E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=76.21

Total Liabilities=Total Assets (Q: Sep. 2019 )-Total Equity (Q: Sep. 2019 )
=129.886-53.673
=76.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunniva Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sunniva's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunniva (XCNQ:SNN) Business Description

Traded in Other Exchanges
N/A
Address
200 Burrard Street, 1200 Waterfront Centre, P.O Box 48600, Vancouver, BC, CAN, V7X 1T2
Sunniva Inc is vertically integrated medical cannabis company committed to delivering safe, low-cost, high-quality products and services at scale. The company is focused on the cultivation, production and distribution of therapeutic solutions targeting two of the medical cannabis markets in the world: Canada and California.
Executives
Mark Hamish Kimmins Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Sunniva (XCNQ:SNN) Headlines

From GuruFocus

Smith+Nephew acquires novel cementless partial knee system

By PRNewswire PRNewswire 01-19-2022

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022

Smith & Nephew Is Reverting to Fair Value

By Praveen Chawla 01-25-2023